TERT promoter mutations and gene amplification: Promoting TERT expression in merkel cell carcinoma

Oncotarget

Volumn 5, Issue 20, 2014, Pages 10048-10057

  Xie, Hong ^a   Liu, Tiantian ^a,b   Wang, Na ^a   Björnhagen, Viveca ^c   Höög, Anders ^a   Larsson, Catharina ^a   Lui, Weng Onn ^a   Xu, Dawei ^c  

^a Cancer Center Karolinska   (Sweden)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gene amplification; MCV; Merkel cell carcinoma; Promoter mutations; Telomerase; TERT

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL LINE; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MERKEL CELL TUMOR; OVERALL SURVIVAL; PROMOTER REGION; SUN EXPOSURE; SURVIVAL TIME; TERT GENE; BIOSYNTHESIS; ENZYMOLOGY; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; SKIN TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; FEMALE; GENE AMPLIFICATION; HUMANS; MALE; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS; TELOMERASE; YOUNG ADULT;

EID: 84919954084     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2491     Document Type: Article

References (38)

1. Schrama D, Ugurel S, Becker J. Merkel cell carcinoma: recent insights and new treatment options. Curr Opin Oncol. 2012; 24: 141-149.
2. Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, Wong SL. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007; 110: 1-12.
3. Chang S, Moore P. Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol. 2012; 7:123-144.
4. Kuwamoto S. Recent advances in the biology of Merkel cell carcinoma. Hum Pathol. 2011; 42: 1063-1077.
5. Becker JC, Schrama D, Houben R. Merkel cell carcinoma. Cell Mol Life Sci. 2009; 66: 1-8.
6. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002; 66: 407-425.
7. Nicholls C, Li H, Wang JQ, Liu JP. Molecular regulation of telomerase activity in aging. Protein Cell. 2011; 2: 726-738.
8. Shay JW, Wright WE: Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011, 21:349-353.
9. Daniel M, Peek GW, Tollefsbol TO. Regulation of the human catalytic subunit of telomerase (hTERT). Gene. 2012; 498: 135-146.
10. Kong F, Zheng C, Xu D. Telomerase as a "stemness" enzyme. Sci China Life Sci. 2014; 57: 564-570.
11. Zhang A, Zheng C, Hou M, Lindvall C, Wallin KL, Angstrom T, Yang X, Hellstrom AC, Blennow E, Bjorkholm M, et al: Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas. Genes Chromosomes Cancer 2002, 34:269-275.
12. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjöld M, Zetterberg A, Björkholm M, Gruber A, Xu D. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 2000; 60: 6230-6235.
13. Melin BS, Nordfjall K, Andersson U, Roos G: hTERT cancer risk genotypes are associated with telomere length. Genet Epidemiol. 2012; 36:368-372.
14. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Jr., Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih IeM, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A. 2013; 110: 6021-6026.
15. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA: Highly recurrent TERT promoter mutations in human melanoma. Science. 2013; 339: 957-959.
16. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, Schadendorf D, Kumar R. TERT promoter mutations in familial and sporadic melanoma. Science. 2013; 339: 959-961.
17. Liu T, Wang N, Cao J, Dinets A, Sofiadis A, Zedenius J, Larsson C, Xu D: The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas. Oncogene. 2013; doi: 10.1038/onc.2013.446.
18. Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P. Frequency of TERT promoter mutations in human cancers. Nat Commun. 2013; 4: 2185.
19. Heidenreich B, Rachakonda P, Hemminki K, Kumar R. TERT promoter mutations in cancer development. Curr Opin Genet Dev. 2014; 24: 30-37.
20. Wang K, Liu T, Liu L, Liu J, Liu C, Ge N, Wang C, Ren H, Yan K, Hu S, Björkholm, Fan Y, Xu D. TERT promoter mutations in renal cell carcinoma and upper tract urothelial carcinoma. Oncotarget. 2014; 5: 1829-1836.
21. Liu T, Liang X, Björkholm M, Jia J, Xu D. The absence of TERT promoter mutations in primary gastric cancer. GENE. 2014; 540: 266-267.
22. Scott G, Laughlin T, Rothberg P. Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma. Mod Pathol. 2014; 27: 516-523.
23. Griewank K, Murali R, Schilling B, Schimming T, Möller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS ONE 2013; 8: e80354.
24. Pópulo H, Boaventura P, Vinagre J, Batista R, Mendes A, Caldas R, Pardal J, Azevedo F, Honavar M, Guimarães I, Manuel Lopes J, Sobrinho-Simões M, Soares P. TERT Promoter Mutations in Skin Cancer: the Effects of Sun Exposure and X-Irradiation. J Invest Dermatol. 2014; 134: 2251-2257.
25. Heidenreich B, Nagore E, Rachakonda P, Garcia-Casado Z, Requena C, Traves V, Becker J, Soufir N, Hemminki K, Kumar R. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat Commun. 2014; 5: 3401.
26. Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer. 2008; 8: 167-179.
27. Boukamp P, Mirancea N. Telomeres rather than telomerase a key target for anti-cancer therapy? Exp Dermatol. 2007; 16: 71-79.
28. Stoppler H, Stoppler MC, Kisiela M, Holzbach A, Moll I, Houdek P, Moll R. Telomerase activity of Merkel cell carcinomas and Merkel cell carcinoma-derived cell cultures. Arch Dermatol Res. 2001; 293: 397-406.
29. Paulson KG, Lemos BD, Feng B, Jaimes N, Penas PF, Bi X, Maher E, Cohen L, Leonard JH, Granter SR, Chin L, Nghiem P. Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol. 2009; 129: 1547-1555.
30. Van Gele M, Leonard JH, Van Roy N, Van Limbergen H, Van Belle S, Cocquyt V, Salwen H, De Paepe A, Speleman F. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer. 2002; 101: 137-145.
31. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008; 319:1096-1100.
32. Strååt K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N, Lou F, Liu Z, Shen J, Jia J, Kyo S, Björkholm M, Sjöberg J, Söderberg-Nauclér C, Xu D. Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst. 2009; 101:488-497.
33. Bellon M, Nicot C. Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst. 2008; 100: 98-108.
34. Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P, Tosolini A, Grobelny JV, Jhanwar SC, Pass HI. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene. 2002; 21:1434-1442.
35. Liu Z, Li Q, Li K, Chen L, Li W, Hou M, Liu T, Yang J, Lindvall C, Bjorkholm M, Jia J, Xu D. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene. 2013; 32: 4203-4213.
36. Xie H, Lee L, Caramuta S, Höög A, Browaldh N, Björnhagen V, Larsson C, Lui W. MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma. J Invest Dermatol. 2014; 134: 507-517.
37. Jung H, Choi Y, Choi J, Roh J, Pyon J, Woo K, Lee E, Jang K, Han J, Park C. Detection of Merkel cell polyomavirus in Merkel cell carcinomas and small cell carcinomas by PCR and immunohistochemistry. Histol Histopathol. 2011; 26: 1231-1241.
38. Duncavage EJ, Le BM, Wang D, Pfeifer JD. Merkel cell polyomavirus: a specific marker for Merkel cell carcinoma in histologically similar tumors. Am J Surg Pathol. 2009; 33: 1771-1777.